Central effects of morphine, levorphanol, (-)-methadone and the opioid-like peptides beta-endorphin and D-alanine2- methionine enkephalinamide on urine volume outflow and electrolytes.
D000818:Animals; D001921:Brain / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects*; D004573:Electrolytes / Q000652:urine*; D004723:Endorphins / Q000494:pharmacology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives*; D004745:Enkephalins / Q000494:pharmacology; D005260:Female; D007981:Levorphanol / Q000494:pharmacology; D008297:Male; D008691:Methadone / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology*; D051381:Rats; D014667:Vasopressins / Q000494:pharmacology; D001615:beta-Endorphin
D004573:Electrolytes; D004723:Endorphins; D004745:Enkephalins; D009294:Narcotics; D014667:Vasopressins; D007981:Levorphanol; D009270:Naloxone; D004744:Enkephalin, Methionine; D001615:beta-Endorphin; C022118:enkephalinamide-Met, Ala(2)-; D009020:Morphine; D008691:Methadone